rs61733359

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_130810.4(DNAAF4):​c.128A>G​(p.Asn43Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000757 in 1,610,242 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0042 ( 6 hom., cov: 32)
Exomes 𝑓: 0.00040 ( 4 hom. )

Consequence

DNAAF4
NM_130810.4 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.61

Publications

3 publications found
Variant links:
Genes affected
DNAAF4 (HGNC:21493): (dynein axonemal assembly factor 4) This gene encodes a tetratricopeptide repeat domain-containing protein. The encoded protein interacts with estrogen receptors and the heat shock proteins, Hsp70 and Hsp90. An homologous protein in rat has been shown to function in neuronal migration in the developing neocortex. A chromosomal translocation involving this gene is associated with a susceptibility to developmental dyslexia. Mutations in this gene are associated with deficits in reading and spelling. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the downstream cell cycle progression 1 (CCPG1) gene. [provided by RefSeq, Mar 2011]
DNAAF4-CCPG1 (HGNC:43019): (DNAAF4-CCPG1 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring dyslexia susceptibility 1 candidate 1 (DYX1C1) and cell cycle progression 1 (CCPG1) genes on chromosome 15. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus unlikely to produce a protein product. [provided by RefSeq, Mar 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0047905147).
BP6
Variant 15-55497855-T-C is Benign according to our data. Variant chr15-55497855-T-C is described in ClinVar as Benign. ClinVar VariationId is 241831.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00422 (642/152254) while in subpopulation AFR AF = 0.0145 (601/41540). AF 95% confidence interval is 0.0135. There are 6 homozygotes in GnomAd4. There are 300 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAAF4NM_130810.4 linkc.128A>G p.Asn43Ser missense_variant Exon 3 of 10 ENST00000321149.7 NP_570722.2 Q8WXU2-1
DNAAF4NM_001033560.2 linkc.128A>G p.Asn43Ser missense_variant Exon 3 of 9 NP_001028732.1 Q8WXU2-2A0A0S2Z5Z4
DNAAF4NM_001033559.3 linkc.128A>G p.Asn43Ser missense_variant Exon 3 of 9 NP_001028731.1 Q8WXU2-3
DNAAF4-CCPG1NR_037923.1 linkn.383A>G non_coding_transcript_exon_variant Exon 2 of 16

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAAF4ENST00000321149.7 linkc.128A>G p.Asn43Ser missense_variant Exon 3 of 10 1 NM_130810.4 ENSP00000323275.3 Q8WXU2-1

Frequencies

GnomAD3 genomes
AF:
0.00414
AC:
630
AN:
152136
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0142
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00203
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00382
GnomAD2 exomes
AF:
0.00106
AC:
261
AN:
247346
AF XY:
0.000809
show subpopulations
Gnomad AFR exome
AF:
0.0133
Gnomad AMR exome
AF:
0.00105
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000549
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000444
Gnomad OTH exome
AF:
0.000661
GnomAD4 exome
AF:
0.000396
AC:
577
AN:
1457988
Hom.:
4
Cov.:
32
AF XY:
0.000312
AC XY:
226
AN XY:
724952
show subpopulations
African (AFR)
AF:
0.0130
AC:
434
AN:
33288
American (AMR)
AF:
0.00107
AC:
47
AN:
43914
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26026
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39648
South Asian (SAS)
AF:
0.0000589
AC:
5
AN:
84836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53372
Middle Eastern (MID)
AF:
0.000868
AC:
5
AN:
5758
European-Non Finnish (NFE)
AF:
0.0000108
AC:
12
AN:
1110868
Other (OTH)
AF:
0.00116
AC:
70
AN:
60278
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
28
56
84
112
140
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00422
AC:
642
AN:
152254
Hom.:
6
Cov.:
32
AF XY:
0.00403
AC XY:
300
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0145
AC:
601
AN:
41540
American (AMR)
AF:
0.00203
AC:
31
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68020
Other (OTH)
AF:
0.00378
AC:
8
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
27
54
80
107
134
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00252
Hom.:
2
Bravo
AF:
0.00459
ESP6500AA
AF:
0.0135
AC:
59
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00130
AC:
158
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.0000546
EpiControl
AF:
0.00

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 25, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
17
DANN
Benign
0.84
DEOGEN2
Benign
0.0014
.;.;T;T
Eigen
Benign
-0.38
Eigen_PC
Benign
-0.20
FATHMM_MKL
Benign
0.47
N
LIST_S2
Uncertain
0.86
D;D;D;.
MetaRNN
Benign
0.0048
T;T;T;T
MetaSVM
Benign
-1.0
T
PhyloP100
1.6
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-0.64
N;N;N;N
REVEL
Benign
0.13
Sift
Benign
0.65
T;T;T;T
Sift4G
Benign
0.60
T;T;T;T
Polyphen
0.37
B;B;B;B
Vest4
0.21
MVP
0.44
MPC
0.051
ClinPred
0.014
T
GERP RS
3.6
PromoterAI
0.093
Neutral
Varity_R
0.058
gMVP
0.14
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61733359; hg19: chr15-55790053; COSMIC: COSV100337015; API